These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15531130)
1. The effects of postmenopausal Vitamin D treatment on vaginal atrophy. Yildirim B; Kaleli B; Düzcan E; Topuz O Maturitas; 2004 Dec; 49(4):334-7. PubMed ID: 15531130 [TBL] [Abstract][Full Text] [Related]
2. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study. Checa MA; Garrido A; Prat M; Conangla M; Rueda C; Carreras R Maturitas; 2005 Sep; 52(1):70-7. PubMed ID: 16143228 [TBL] [Abstract][Full Text] [Related]
3. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Simon JA; Reape KZ; Wininger S; Hait H Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998 [TBL] [Abstract][Full Text] [Related]
4. Effect of estradiol valerate and levonorgestrel on vaginal health. Manonai J; Chittacharoen A; Theppisai U Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354 [TBL] [Abstract][Full Text] [Related]
5. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H Menopause; 2009; 16(4):735-41. PubMed ID: 19252451 [TBL] [Abstract][Full Text] [Related]
6. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105 [TBL] [Abstract][Full Text] [Related]
7. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women. Bachmann GA; Schaefers M; Uddin A; Utian WH Menopause; 2009; 16(5):877-82. PubMed ID: 19458560 [TBL] [Abstract][Full Text] [Related]
8. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J Menopause; 2009; 16(5):907-22. PubMed ID: 19436225 [TBL] [Abstract][Full Text] [Related]
9. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study. Jonasson AF; Edwall L; Uvnäs-Moberg K Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944 [TBL] [Abstract][Full Text] [Related]
10. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Martel C; Balser J Gynecol Endocrinol; 2010 Jul; 26(7):524-32. PubMed ID: 20459349 [TBL] [Abstract][Full Text] [Related]
11. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843 [TBL] [Abstract][Full Text] [Related]
12. Effect of Pueraria mirifica on vaginal health. Manonai J; Chittacharoen A; Theppisai U; Theppisai H Menopause; 2007; 14(5):919-24. PubMed ID: 17415017 [TBL] [Abstract][Full Text] [Related]
13. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509 [TBL] [Abstract][Full Text] [Related]
14. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845 [TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone and raloxifene on health-related quality of life and sexual function. Nijland EA; Weijmar Schultz WC; Davis SR Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial. Costantino D; Guaraldi C Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203 [TBL] [Abstract][Full Text] [Related]
17. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Bachmann GA; Komi JO; Menopause; 2010; 17(3):480-6. PubMed ID: 20032798 [TBL] [Abstract][Full Text] [Related]
18. Effect of Foeniculum vulgare (fennel) on vaginal atrophy in postmenopausal women: A double-blind, randomized, placebo-controlled trial. Ghazanfarpour M; Shokrollahi P; Khadivzadeh T; Baharian Sharghi N; Mirzaii Najmabadi K; Babakhanian M; Jafarian AH Post Reprod Health; 2017 Dec; 23(4):171-176. PubMed ID: 28990439 [TBL] [Abstract][Full Text] [Related]
19. Serum vitamin D status of Korean postmenopausal women during the winter months. Lee ES; Ahn J; Park HM Asia Pac J Clin Nutr; 2009; 18(1):29-33. PubMed ID: 19329392 [TBL] [Abstract][Full Text] [Related]
20. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR Menopause; 2008; 15(1):94-7. PubMed ID: 17882008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]